Efficacy and safety of dapagliflozin in Asian patients with type 2 diabetes after metformin failure: A randomized controlled trial

ConclusionsDapagliflozin 5 or 10 mg as add‐on to metformin was well tolerated in Asian patients with T2DM and significantly improved glycemic control with the additional benefit of weight reduction.

Source: Journal of Diabetes - November 1, 2015 Category: Endocrinology Authors: Wenying Yang, Ping Han, Kyung‐Wan Min, Bei Wang, Traci Mansfield, Caroline T'Joen, Nayyar Iqbal, Eva Johnsson, Agata Ptaszynska Tags: Original Article Source Type: research